Dr. Marija Grozdanić

Dr. Marija Grozdanić started her undergraduate studies in 2009 at the University of Belgrade, Faculty of Physical Chemistry. She completed her undergraduate studies in 2013. In 2013, she continued her education and started master's studies at the University of Belgrade, Faculty of Physical Chemistry, specializing in Biophysical Chemistry. She completed her master's studies in 2015 and in the same year started doctoral studies at the International Postgraduate School Jožef Stefan, program Nanoscience and Nanotechnology , in Ljubljana, Slovenia. Her research, under the mentorship of Prof. Dr. Marko Fonović, was funded by the ARIS agency (Slovenian Research and Innovation Agency). She defended her doctoral dissertation titled "Cathepsin cleavage of epidermal growth factor receptor (EGFR) affects signaling pathways of cancer cells" on December 20, 2024. From 2015 to 2023, Marija was employed at the Jožef Stefan Institute, Department for Biochemistry, Molecular and Structural Biology, first as a young researcher from 2015 to 2019, and then as an assistant from 2020 to 2023. Since February 2024, Dr. Marija Grozdanić has been working as a research associate at the Institute for Biological Research "Siniša Stanković", Department of Neurobiology.

Her scientific research has been carried out through participation in the following projects:
2015-2019 Research and infrastructure project of the ARIS agency (the Slovenian Research and Innovation Agency) "Proteolysis and its regulation," led by Prof. Dr. Boris Turk.
2021 Research project of the ARIS agency (the Slovenian Research and Innovation Agency) "Cathepsin-based non-invasive diagnostics of cancer," led by Prof. Dr. Boris Turk.
2021-2023 Research project of the ARIS agency (the Slovenian Research and Innovation Agency) "Systemic determination of legumain physiological roles," led by Prof. Dr. Marko Fonović.

She is a member of the following scientific societies:
• Slovenian Biochemical Society (SBD)
• Serbian Biochemical Society (BDS)
• Serbian Association for Cancer Research (SDIR)